Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
class of drugs
|
| gptkbp:cause |
hallucinations
sleepwalking next-day impairment |
| gptkbp:contraindication |
severe liver impairment
history of substance abuse |
| gptkbp:developedAsAlternativeTo |
gptkb:benzodiazepines
|
| gptkbp:eliminationRoute |
renal
|
| gptkbp:hasMember |
gptkb:zopiclone
gptkb:eszopiclone gptkb:zolpidem gptkb:zaleplon |
| https://www.w3.org/2000/01/rdf-schema#label |
z-drugs
|
| gptkbp:introducedIn |
1990s
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
non-benzodiazepine hypnotics
|
| gptkbp:mechanismOfAction |
GABA-A receptor agonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:notRecommendedFor |
long-term use
|
| gptkbp:regulates |
controlled substance in many countries
|
| gptkbp:riskFactor |
dependence
withdrawal symptoms complex sleep behaviors |
| gptkbp:shouldNotBeCombinedWith |
gptkb:beer
gptkb:CNS_depressants |
| gptkbp:sideEffect |
dizziness
headache drowsiness memory impairment |
| gptkbp:usedFor |
treatment of insomnia
|
| gptkbp:bfsParent |
gptkb:gamma-aminobutyric_acid_receptor
|
| gptkbp:bfsLayer |
6
|